The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

ABSTRACT: Conjugation or fusion to AlbudAbs™ (albumin-binding domain antibodies) is a novel approach to extend the half-life and alter the tissue distribution of biological and small molecule therapeutics. To understand extravasation kinetics and extravascular organ concentrations of AlbudAbs in hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorneloe, Kevin S., Sepp, Armin, Zhang, Sean, Galinanes-Garcia, Laura, Galette, Paul, Al-Azzam, Wasfi, Vugts, Danielle J., van Dongen, Guus, Elsinga, Phillip, Wiegers, Johan, Glaudemans, Andor W. J. M., Vincent, Veena, Renaux, Jessica, Szapacs, Matt, Birchler, Mary, Cleveland, Matthew, Bergstrom, Mats, Davies, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529487/
https://www.ncbi.nlm.nih.gov/pubmed/31115711
http://dx.doi.org/10.1186/s13550-019-0514-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529487/
https://www.ncbi.nlm.nih.gov/pubmed/31115711
http://dx.doi.org/10.1186/s13550-019-0514-9

Ejemplares similares